Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Thursday, July 31, 2025

Lucintel Forecasts the Global Methyl 2-Fluoro-3-Oxopentanoate Market to Grow with a CAGR of 5.6% from 2025 to 2031

According to a market report by Lucintel, the future of the global methyl 2-fluoro-3-oxopentanoate market looks promising with opportunities in the organic synthesis and pharmaceutical markets. The global methyl 2-fluoro-3-oxopentanoate market is expected to grow with a CAGR of 5.6% from 2025 to 2031. The major drivers for this market are the rising demand in pharmaceutical applications, the growing use in agrochemical formulations, and the increasing research & development activities.

A more than 150-page report to understand trends, opportunity and forecast in global methyl 2-fluoro-3-oxopentanoate market to 2031 by type (purity≥95% and purity≥99%), application (organic synthesis, pharmaceutical, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that, within the type category, purity ≥ 95% is expected to witness higher growth over the forecast period.

Within the application category, pharmaceutical is expected to witness higher growth.

Download sample by clicking on methyl 2-fluoro-3-oxopentanoate market.

In terms of region, North America is expected to witness the highest growth over the forecast period.

Anhui Jinquan Biotechnology, Hangzhou ICH Biofarm, Fangde New Materials, Jostrong (Tianjin) Technology, Tianmen Hengchang Chemical are the major suppliers in the methyl 2-fluoro-3-oxopentanoate market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. +1-972-636-5056

Explore Our Latest Publications

CD19 Target Drug Market

CD20 Target Drug Market

Hot Biopsy Forcep Market

Molecular Beam Epitaxy System Market

Molecular Interaction Analyzer Market

No comments:

Post a Comment